1、论文标题： Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
DOI： 10.1136/jitc-2022-004691
发表时间： 2022-05-01
期刊： Journal for ImmunoTherapy of Cancer
影响因子： 13.751
货号： ZQ0020
产品名称： MHCC97H cells
原文链接： https://jitc.bmj.com/content/10/5/e004691.abstract

2、论文标题： EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop
DOI： 10.1016/j.omtn.2021.06.002
发表时间： 2021-06-12
期刊： Molecular Therapy-Nucleic Acids
影响因子： 8.886
货号： ZQ0020
产品名称： MHCC-97H cells
原文链接： https://www.sciencedirect.com/science/article/pii/S2162253121001438

3、论文标题： EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli
DOI： 10.1038/s41419-022-04796-8
发表时间： 2022-04-15
期刊： Cell Death & Disease
影响因子： 8.469
货号： ZQ0020
产品名称： MHCC-97H cells
原文链接： https://www.nature.com/articles/s41419-022-04796-8

4、论文标题： DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination
DOI： 10.1186/s13578-021-00555-y
发表时间： 2021-02-23
期刊： Cell and Bioscience
影响因子： 7.133
货号： ZQ0020
产品名称： MHCC97H cells
原文链接： https://cellandbioscience.biomedcentral.com/articles/10.1186/s13578-021-00555-y

5、论文标题： COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis
DOI： 10.3389/fphar.2021.619732
发表时间： 2021-03-31
期刊： Frontiers in Pharmacology
影响因子： 5.811
货号： ZQ0020
产品名称： MHCC97-H cells
原文链接： https://www.frontiersin.org/articles/10.3389/fphar.2021.619732/full

6、论文标题： HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway
DOI： 10.1111/cpr.12835
发表时间： 2020-06-17
期刊： CELL PROLIFERATION
影响因子： 5.753
货号： ZQ0020
产品名称： MHCC-97H cells
原文链接： https://onlinelibrary.wiley.com/doi/abs/10.1111/cpr.12835

7、论文标题： Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
DOI： 10.3748/wjg.v27.i23.3327
发表时间： 2021-06-21
期刊： WORLD JOURNAL OF GASTROENTEROLOGY
影响因子： 5.742
货号： ZQ0020
产品名称： MHCC-97H cells
原文链接： https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218352/

8、论文标题： Glycopattern Alteration of Glycoproteins in Gastrointestinal Cancer Cell Lines and Their Cell-Derived Exosomes
DOI： 10.1021/acs.jproteome.2c00159
发表时间： 2022-07-05
期刊： JOURNAL OF PROTEOME RESEARCH
影响因子： 5.37
货号： ZQ0020
产品名称： MHCC-97H cells
原文链接： https://pubs.acs.org/doi/abs/10.1021/acs.jproteome.2c00159

9、论文标题： Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway
DOI： 10.1016/j.phymed.2021.153575
发表时间： 2021-04-18
期刊： PHYTOMEDICINE
影响因子： 5.34
货号： ZQ0020
产品名称： MHCC97H cells

原文链接： https://www.sciencedirect.com/science/article/pii/S0944711321001173

10、论文标题： SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling
DOI： 10.1111/jcmm.15693
发表时间： 2020-08-03
期刊： JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
影响因子： 4.486
货号： ZQ0020
产品名称： MHCC-97H cells
原文链接： https://onlinelibrary.wiley.com/doi/abs/10.1111/jcmm.15693

11、论文标题： MARCH6 promotes hepatocellular carcinoma development through up-regulation of ATF2
DOI： 10.1186/s12885-021-08540-x
发表时间： 2021-07-17
期刊： BMC CANCER
影响因子： 4.43
货号： ZQ0020
产品名称： MHCC97H cells
原文链接： https://link.springer.com/article/10.1186/s12885-021-08540-x

12、论文标题： Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma
DOI： 10.1016/j.biopha.2019.109780
发表时间： 2019-12-31
期刊： BIOMEDICINE & PHARMACOTHERAPY
影响因子： 3.743
货号： ZQ0020
产品名称： MHCC-97H cells
原文链接： https://www.sciencedirect.com/science/article/pii/S0753332219354022

13、论文标题： Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma
DOI： 10.1002/cam4.2618
发表时间： 2019-11-01
期刊： Cancer Medicine
影响因子： 3.357
货号： ZQ0020
产品名称： MHCC-97H cells
原文链接： https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.2618

14、论文标题： Linc00601 upregulation promotes hepatocellular carcinoma development by activating MAPK signaling pathway
DOI： 10.26355/eurrev_202006_21498
发表时间： 2020-06-01
期刊： European Review for Medical and Pharmacological Sciences
影响因子： 3.024
货号： ZQ0020
产品名称： MHCC97-H cells
原文链接： https://pubmed.ncbi.nlm.nih.gov/32572918/

15、论文标题： COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling
DOI： 10.1016/j.jep.2017.07.007
发表时间： 2017-07-08
期刊： JOURNAL OF ETHNOPHARMACOLOGY
影响因子： 2.981
货号： ZQ0020
产品名称： MHCC97-H cells
原文链接： https://www.sciencedirect.com/science/article/pii/S0378874116317640

16、论文标题： RNA sequencing identifies two novel liver-specific long noncoding RNAs with potential diagnostic value in hepatocellular carcinoma
DOI： 10.2217/bmm-2020-0825
发表时间： 2021-06-15
期刊： Biomarkers in Medicine
影响因子： 2.851
货号： ZQ0020
产品名称： MHCC97-H cells
原文链接： https://www.futuremedicine.com/doi/abs/10.2217/bmm-2020-0825

17、论文标题： FK866 inhibits the epithelial‑mesenchymal transition of hepatocarcinoma MHCC97‑H cells
DOI： 10.3892/ol.2018.9541
发表时间： 2018-10-03
期刊： Oncology Letters
影响因子： 1.664
货号： ZQ0020
产品名称： human liver tumor cell line MHCC97-H

原文链接： https://www.spandidos-publications.com/10.3892/ol.2018.9541

PubMed=11819844; DOI=10.3748/wjg.v7.i5.630; PMCID=PMC4695564
Li Y., Tang Z.-Y., Ye S.-L., Liu Y.-K., Chen J., Xue Q., Chen J., Gao D.-M., Bao W.-H.
Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.
World J. Gastroenterol. 7:630-636(2001)

PubMed=15048980; DOI=10.1002/pmic.200300653
Ding S.-J., Li Y., Shao X.-X., Zhou H., Zeng R., Tang Z.-Y., Xia Q.-C.
Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials.
Proteomics 4:982-994(2004)

PubMed=15146329; DOI=10.1007/s00432-004-0564-9
Li Y., Tian B., Yang J., Zhao L., Wu X., Ye S.-L., Liu Y.-K., Tang Z.-Y.
Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.
J. Cancer Res. Clin. Oncol. 130:460-468(2004)

PubMed=23505090; DOI=10.1002/hep.26402
Wang K., Lim H.Y., Shi S., Lee J., Deng S.-B., Xie T., Zhu Z., Wang Y.-L., Pocalyko D., Yang W.J., Rejto P.A., Mao M., Park C.-K., Xu J.-C.
Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Hepatology 58:706-717(2013)

PubMed=25690035; DOI=10.3390/ijms16024209; PMCID=PMC4346953
Tian M.-M., Cheng H., Wang Z.-Q., Su N., Liu Z.-X., Sun C.-Q., Zhen B., Hong X.-C., Xue Y., Xu P.
Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-H.
Int. J. Mol. Sci. 16:4209-4225(2015)

PubMed=25886575; DOI=10.1186/s12885-015-1166-4; PMCID=PMC4380258
Dang H., Steinway S.N., Ding W., Rountree C.B. Jr.
Induction of tumor initiation is dependent on CD44s in c-Met(+) hepatocellular carcinoma.
BMC Cancer 15:161.1-161.11(2015)

PubMed=31063779; DOI=10.1053/j.gastro.2019.05.001
Caruso S., Calatayud A.-L., Pilet J., La Bella T., Rekik S., Imbeaud S., Letouze E., Meunier L., Bayard Q., Rohr-Udilova N., Peneau C., Grasl-Kraupp B., de Koning L., Ouine B., Bioulac-Sage P., Couchy G., Calderaro J., Nault J.-C., Zucman-Rossi J., Rebouissou S.
Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response.
Gastroenterology 157:760-776(2019)

PubMed=31378681; DOI=10.1016/j.ccell.2019.07.001; PMCID=PMC7505724
Qiu Z.-X., Li H., Zhang Z.-T., Zhu Z.-F., He S., Wang X.-J., Wang P.-C., Qin J.-J., Zhuang L.-P., Wang W., Xie F.-B., Gu Y., Zou K.-K., Li C., Li C., Wang C.-H., Cen J., Chen X.-T., Shu Y.-J., Zhang Z., Sun L.-L., Min L.-H., Fu Y., Huang X.-W., Lv H., Zhou H., Ji Y., Zhang Z.-G., Meng Z.-Q., Shi X.-L., Zhang H.-B., Li Y.-X., Hui L.-J.
A pharmacogenomic landscape in human liver cancers.
Cancer Cell 36:179-193.e11(2019)

PubMed=32884988; DOI=10.1016/j.gendis.2019.12.008; PMCID=PMC7452459
Lin Y.-L., Li Y.
Study on the hepatocellular carcinoma model with metastasis.
Genes Dis. 7:336-350(2020)